We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

AC Immune's robust pipeline

Our robust and diverse pipeline of eleven therapeutic and three diagnostic product candidates has the potential to greatly improve the treatment of Alzheimer’s and other neurodegenerative diseases. All of the company’s products were developed utilizing its proprietary SupraAntigen™ and Morphomer™ technology platforms.